title: Biomarkers for early detection of high risk cancers: from gliomas to nasopharyngeal carcinoma.
abstract: Nasopharyngeal carcinoma (NpC) is a malignant disease associated with Epstein-Barr virus infection, and often diagnosed at an advanced stage. This significantly curtails patient survival. We hypothesize that a panel of biomarkers can be assembled to assess NpC incidence, early detection, and tumor progression during therapeutic intervention. Our thesis rests on a model of successfully predicting high-risk gliomas by means of a carefully crafted panel of molecular mitotic biomarkers (i.e., securin, survivin and MCM2). The strategy we propose holds strong promise for prevention and cure of NpC. The approach we propose seeks to identify certain biomarkers from viral materials, patient tissues and assessment of related diseases, whose signatures, taken together, will be endowed with some degree of congruency, or sense of a coordinated language (i.e., "votes"). Biomarker "voting" will then permit to outline a broad coordinated molecular map for the molecular and epigenetic characterization of each individual patient's NpC tumor. We will draw on the process of contrasting biomarkers in health and disease, which rests on the auto-proteomic concept particularly relevant in high-risk cancer individuals, such as is the case for NpC. In brief we defend, current advances in human proteome profiling proffers the possibility of having individual baseline proteomic profiles using local body fluids (e.g., saliva, nasal secretions, sputum) or systemic fluids (e.g., plasma, serum, cerebrospinal fluid) to unravel a personalized molecular map for high-risk NpC individuals. Regular check-up will monitor for new or impending manifestations of NpC, and provide a secure assessment of incidence and early detection.
authors.affiliation: Division of Oral Biology and Medicine, UCLA School of Dentistry, Los Angeles, CA 90095, USA.
authors.forename: Oluwadayo
authors.initials: O
authors.lastname: Oluwadara
authors.forename: Francesco
authors.initials: F
authors.lastname: Chiappelli
references.citation: Clin Chem. 2002 Aug;48(8):1296-304
references.pmid: 12142387
references.citation: JAMA. 2008 Sep 24;300(12):1417-22
references.pmid: 18812532
references.citation: J Virol. 2000 Nov;74(21):10223-8
references.pmid: 11024153
references.citation: Bioinformation. 2006 Dec 29;1(8):331-4
references.pmid: 17597915
references.citation: Cancer Res. 2004 Sep 15;64(18):6503-10
references.pmid: 15374961
references.citation: J Am Dent Assoc. 2006 Mar;137(3):313-21
references.pmid: 16570464
references.citation: Epidemiol Rev. 1993;15(2):466-85
references.pmid: 8174667
references.citation: Cancer. 1980 Nov 1;46(9):2100-6
references.pmid: 6253051
references.citation: EMBO J. 1998 Mar 16;17(6):1700-9
references.pmid: 9501091
references.citation: Nat Rev Cancer. 2004 Oct;4(10):757-68
references.pmid: 15510157
references.citation: Science. 2003 Mar 14;299(5613):1679-80
references.pmid: 12637728
references.citation: Cell. 1995 Feb 10;80(3):389-99
references.pmid: 7859281
references.citation: Int J Cancer. 2003 Mar 1;103(6):745-51
references.pmid: 12516093
references.citation: Eur J Hum Genet. 2005 Feb;13(2):248-52
references.pmid: 15483644
references.citation: J Virol. 1990 May;64(5):2309-18
references.pmid: 2157887
references.citation: Cancer Prev Res (Phila). 2008 Jun;1(1):12-4
references.pmid: 19138931
references.citation: Nature. 2008 Apr 3;452(7187):571-9
references.pmid: 18385731
references.citation: Clin Otolaryngol Allied Sci. 2001 Apr;26(2):82-92
references.pmid: 11309046
references.citation: Comp Funct Genomics. 2007;:57513
references.pmid: 18288251
references.citation: Hum Pathol. 1990 Aug;21(8):805-10
references.pmid: 2167287
references.citation: Cell Mol Life Sci. 2008 Apr;65(7-8):1007-12
references.pmid: 18213447
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1765-77
references.pmid: 17035381
references.citation: Int J Cancer. 1990 Jun 15;45(6):1033-9
references.pmid: 2351484
references.citation: Semin Cancer Biol. 2002 Dec;12(6):431-41
references.pmid: 12450729
references.citation: Bioinformation. 2008;3(1):47-52
references.pmid: 19052666
references.citation: Science. 1997 Nov 7;278(5340):1054-9
references.pmid: 9353179
references.citation: Semin Cancer Biol. 2001 Dec;11(6):461-7
references.pmid: 11669608
references.citation: J Virol. 2000 Nov;74(22):10681-9
references.pmid: 11044112
references.citation: Science. 1999 Oct 15;286(5439):531-7
references.pmid: 10521349
references.citation: EMBO J. 1997 Oct 15;16(20):6131-40
references.pmid: 9359753
references.citation: J Immunol. 2000 Sep 15;165(6):2975-81
references.pmid: 10975805
references.citation: Int J Cancer. 2000 Feb 1;85(3):358-63
references.pmid: 10652427
references.citation: Oncogene. 2002 Aug 12;21(35):5450-61
references.pmid: 12154407
references.citation: J Natl Cancer Inst. 1990 Feb 21;82(4):291-6
references.pmid: 2299678